BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Spinazzola A. Mitochondrial DNA mutations and depletion in pediatric medicine. Seminars in Fetal and Neonatal Medicine 2011;16:190-6. [DOI: 10.1016/j.siny.2011.04.011] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Bosemani T, Anghelescu C, Boltshauser E, Hoon AH Jr, Pearl PL, Craiu D, Johnston MV, Huisman TA, Poretti A. Subthalamic nucleus involvement in children: a neuroimaging pattern-recognition approach. Eur J Paediatr Neurol 2014;18:249-56. [PMID: 24149100 DOI: 10.1016/j.ejpn.2013.09.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
2 Lee SR, Han J. Mitochondrial Mutations in Cardiac Disorders. Adv Exp Med Biol 2017;982:81-111. [PMID: 28551783 DOI: 10.1007/978-3-319-55330-6_5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
3 El-hattab AW, Dai H, Almannai M, Wang J, Faqeih EA, Al Asmari A, Saleh MAM, Elamin MAO, Alfadhel M, Alkuraya FS, Hashem M, Aldosary MS, Almass R, Almutairi FB, Alsagob M, Al-owain M, Al-sharfa S, Al-hassnan ZN, Rahbeeni Z, Al-muhaizea MA, Makhseed N, Foskett GK, Stevenson DA, Gomez-ospina N, Lee C, Boles RG, Schrier Vergano SA, Wortmann SB, Sperl W, Opladen T, Hoffmann GF, Hempel M, Prokisch H, Alhaddad B, Mayr JA, Chan W, Kaya N, Wong LC. Molecular and clinical spectra of FBXL4 deficiency. Human Mutation 2017;38:1649-59. [DOI: 10.1002/humu.23341] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
4 Finsterer J, G Kovacs G, Ahting U. Adult mitochondrial DNA depletion syndrome with mild manifestations. Neurol Int. 2013;5:28-30. [PMID: 23888212 DOI: 10.4081/ni.2013.e9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
5 Pearce S, Nezich CL, Spinazzola A. Mitochondrial diseases: translation matters. Mol Cell Neurosci 2013;55:1-12. [PMID: 22986124 DOI: 10.1016/j.mcn.2012.08.013] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 4.9] [Reference Citation Analysis]
6 Millan MJ. An epigenetic framework for neurodevelopmental disorders: from pathogenesis to potential therapy. Neuropharmacology 2013;68:2-82. [PMID: 23246909 DOI: 10.1016/j.neuropharm.2012.11.015] [Cited by in Crossref: 145] [Cited by in F6Publishing: 118] [Article Influence: 14.5] [Reference Citation Analysis]
7 Almannai M, El-Hattab AW, Scaglia F. Mitochondrial DNA replication: clinical syndromes. Essays Biochem 2018;62:297-308. [PMID: 29950321 DOI: 10.1042/EBC20170101] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
8 Tseng YT, Li SW, HuangFu WC, Yen Y, Liu IH. The single nucleotide variant at c.662A>G in human RRM2B is a loss-of-function mutation. Mol Genet Genomic Med 2020;8:e1497. [PMID: 32931159 DOI: 10.1002/mgg3.1497] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 El-Hattab AW, Wang J, Dai H, Almannai M, Staufner C, Alfadhel M, Gambello MJ, Prasun P, Raza S, Lyons HJ, Afqi M, Saleh MAM, Faqeih EA, Alzaidan HI, Alshenqiti A, Flore LA, Hertecant J, Sacharow S, Barbouth DS, Murayama K, Shah AA, Lin HC, Wong LC. MPV17-related mitochondrial DNA maintenance defect: New cases and review of clinical, biochemical, and molecular aspects. Hum Mutat 2018;39:461-70. [PMID: 29282788 DOI: 10.1002/humu.23387] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
10 Wong LJ. Next generation molecular diagnosis of mitochondrial disorders. Mitochondrion 2013;13:379-87. [PMID: 23473862 DOI: 10.1016/j.mito.2013.02.001] [Cited by in Crossref: 52] [Cited by in F6Publishing: 37] [Article Influence: 5.8] [Reference Citation Analysis]
11 Brunel-guitton C, Levtova A, Sasarman F. Mitochondrial Diseases and Cardiomyopathies. Canadian Journal of Cardiology 2015;31:1360-76. [DOI: 10.1016/j.cjca.2015.08.017] [Cited by in Crossref: 40] [Cited by in F6Publishing: 28] [Article Influence: 5.7] [Reference Citation Analysis]
12 Dames S, Chou LS, Xiao Y, Wayman T, Stocks J, Singleton M, Eilbeck K, Mao R. The development of next-generation sequencing assays for the mitochondrial genome and 108 nuclear genes associated with mitochondrial disorders. J Mol Diagn 2013;15:526-34. [PMID: 23665194 DOI: 10.1016/j.jmoldx.2013.03.005] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
13 Siebel S, Solomon BD. Mitochondrial Factors and VACTERL Association-Related Congenital Malformations. Mol Syndromol 2013;4:63-73. [PMID: 23653577 DOI: 10.1159/000346301] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
14 Wang J, Zhan H, Li FY, Pursley AN, Schmitt ES, Wong LJ. Targeted array CGH as a valuable molecular diagnostic approach: experience in the diagnosis of mitochondrial and metabolic disorders. Mol Genet Metab 2012;106:221-30. [PMID: 22494545 DOI: 10.1016/j.ymgme.2012.03.005] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
15 Wong LC. Biochemical and Molecular Methods for the Study of Mitochondrial Disorders. In: Wong LC, editor. Mitochondrial Disorders Caused by Nuclear Genes. New York: Springer; 2013. pp. 27-45. [DOI: 10.1007/978-1-4614-3722-2_2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
16 Moran MM, Allen NM, Treacy EP, King MD. “Stiff Neonate” With Mitochondrial DNA Depletion and Secondary Neurotransmitter Defects. Pediatric Neurology 2011;45:403-5. [DOI: 10.1016/j.pediatrneurol.2011.08.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
17 Montero R, Grazina M, López-gallardo E, Montoya J, Briones P, Navarro-sastre A, Land JM, Hargreaves IP, Artuch R, del Mar O'callaghan M, Jou C, Jimenez C, Buján N, Pineda M, García-cazorla A, Nascimento A, Perez-dueñas B, Ruiz-pesini E, Fratter C, Salviati L, Simões M, Mendes C, Santos MJ, Diogo L, Garcia P, Navas P. Coenzyme Q10 deficiency in mitochondrial DNA depletion syndromes. Mitochondrion 2013;13:337-41. [DOI: 10.1016/j.mito.2013.04.001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]
18 Hazard FK, Ficicioglu CH, Ganesh J, Ruchelli ED. Liver pathology in infantile mitochondrial DNA depletion syndrome. Pediatr Dev Pathol 2013;16:415-24. [PMID: 24050659 DOI: 10.2350/12-07-1229-OA.1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
19 Holt IJ, Jacobs HT. Unique features of DNA replication in mitochondria: a functional and evolutionary perspective. Bioessays 2014;36:1024-31. [PMID: 25220172 DOI: 10.1002/bies.201400052] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
20 Niyazov DM, Kahler SG, Frye RE. Primary Mitochondrial Disease and Secondary Mitochondrial Dysfunction: Importance of Distinction for Diagnosis and Treatment. Mol Syndromol 2016;7:122-37. [PMID: 27587988 DOI: 10.1159/000446586] [Cited by in Crossref: 86] [Cited by in F6Publishing: 81] [Article Influence: 14.3] [Reference Citation Analysis]
21 El-Hattab AW, Scaglia F. Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options. Neurotherapeutics 2013;10:186-98. [PMID: 23385875 DOI: 10.1007/s13311-013-0177-6] [Cited by in Crossref: 163] [Cited by in F6Publishing: 142] [Article Influence: 18.1] [Reference Citation Analysis]
22 Pagano G, Talamanca AA, Castello G, d'Ischia M, Pallardó FV, Petrović S, Porto B, Tiano L, Zatterale A. From clinical description, to in vitro and animal studies, and backward to patients: oxidative stress and mitochondrial dysfunction in Fanconi anemia. Free Radic Biol Med 2013;58:118-25. [PMID: 23376230 DOI: 10.1016/j.freeradbiomed.2013.01.015] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
23 Jacinto S, Guerreiro P, de Oliveira RM, Cunha-Oliveira T, Santos MJ, Grazina M, Rego AC, Outeiro TF. MPV17 Mutations Are Associated With a Quiescent Energetic Metabolic Profile. Front Cell Neurosci 2021;15:641264. [PMID: 33815063 DOI: 10.3389/fncel.2021.641264] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
24 Löllgen S, Weiher H. The role of the Mpv17 protein mutations of which cause mitochondrial DNA depletion syndrome (MDDS): lessons from homologs in different species. Biol Chem 2015;396:13-25. [PMID: 25205723 DOI: 10.1515/hsz-2014-0198] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
25 Iommarini L, Peralta S, Torraco A, Diaz F. Mitochondrial Diseases Part II: Mouse models of OXPHOS deficiencies caused by defects in regulatory factors and other components required for mitochondrial function. Mitochondrion 2015;22:96-118. [PMID: 25640959 DOI: 10.1016/j.mito.2015.01.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
26 El-Hattab AW, Craigen WJ, Scaglia F. Mitochondrial DNA maintenance defects. Biochim Biophys Acta Mol Basis Dis 2017;1863:1539-55. [PMID: 28215579 DOI: 10.1016/j.bbadis.2017.02.017] [Cited by in Crossref: 107] [Cited by in F6Publishing: 99] [Article Influence: 21.4] [Reference Citation Analysis]